Cargando…

Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune-related adverse events among cancer patients

Immune checkpoint inhibitors (ICIs) have fundamentally changed the treatment landscape of various cancers. While ICI treatments result in improved survival, quality of life and are cost-effective, the majority of patients experience at least one immune-related adverse event (irAE). Many of these sid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Özdemir, Berna C., Espinosa da Silva, Cristina, Arangalage, Dimitri, Monney, Pierre, Guler, Sabina A., Huynh-Do, Uyen, Stirnimann, Guido, Possamai, Lucia, Trepp, Roman, Hoepner, Robert, Salmen, Anke, Gerard, Camille L., Hruz, Petr, Christ, Lisa, Rothschild, Sacha I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264466/ https://www.ncbi.nlm.nih.gov/pubmed/37017694 http://dx.doi.org/10.1007/s00262-023-03436-0

Ejemplares similares

Correction to: Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune‑related adverse events among cancer patients
por: Özdemir, Berna C., et al.
Publicado: (2023)

Acute cardiac manifestations under immune checkpoint inhibitors—beware of the obvious: a case report
por: Arangalage, Dimitri, et al.
Publicado: (2021)

The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data
por: Salmen, Anke, et al.
Publicado: (2023)

Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System
por: Pistor, Maximilian, et al.
Publicado: (2021)

Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis
por: Marti, Stefanie, et al.
Publicado: (2023)

Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis
por: Hoepner, Robert, et al.
Publicado: (2014)

Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge
por: Diem, Lara, et al.
Publicado: (2021)

Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort
por: Pistor, Maximilian, et al.
Publicado: (2022)

Toxicity, disease management and outcome of treatment with immune checkpoint inhibitors by sex in patients with cancer and preexisting autoimmune disease
por: Liu, Michael, et al.
Publicado: (2023)

Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?
por: Hoepner, Robert, et al.
Publicado: (2022)

Feasibility of adenosine stress cardiovascular magnetic resonance perfusion imaging in patients with MR-conditional transvenous permanent pacemakers and defibrillators
por: Pavon, Anna Giulia, et al.
Publicado: (2022)

Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System
por: Pistor, Maximilian, et al.
Publicado: (2022)

Plasminogen Activator Inhibitor-1: Another String in the Platelet-Derived Extracellular Vesicles Bow?
por: Arangalage, Dimitri, et al.
Publicado: (2022)

Myocardial extracellular volume by T1 mapping: a new marker of arrhythmia in mitral valve prolapse
por: Pavon, Anna Giulia, et al.
Publicado: (2021)

An algorithm using clinical data to predict the optimal individual glucocorticoid dosage to treat multiple sclerosis relapses
por: Gili-Kovács, Judit, et al.
Publicado: (2021)

Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study
por: Miclea, Andrei, et al.
Publicado: (2019)

Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age
por: Briner, Myriam, et al.
Publicado: (2019)

In Vivo and In Vitro Evidence for an Interplay between the Glucocorticoid Receptor and the Vitamin D Receptor Signaling
por: Bagnoud, Maud, et al.
Publicado: (2023)

Sex and Gender Differences in Anticancer Treatment Toxicity: A Call for Revisiting Drug Dosing in Oncology
por: Özdemir, Berna C, et al.
Publicado: (2022)

Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational study
por: Diem, Lara, et al.
Publicado: (2020)

Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study
por: Chaloulos-Iakovidis, Panagiotis, et al.
Publicado: (2021)

No optical coherence tomography changes in premanifest Huntington's disease mutation carriers far from disease onset
por: Schmid, Rahel Dominique, et al.
Publicado: (2022)

c-Jun N-Terminal Kinase as a Therapeutic Target in Experimental Autoimmune Encephalomyelitis
por: Bagnoud, Maud, et al.
Publicado: (2020)

Multiple sclerosis as a model to investigate SARS‐CoV‐2 effect on brain atrophy
por: Rebsamen, Michael, et al.
Publicado: (2022)

Cancer researchers’ perceptions of the importance of the sex of cell lines, animals, and human samples for cancer biology research
por: Özdemir, Berna C., et al.
Publicado: (2023)

Additional value of cardiac magnetic resonance feature tracking parameters for the evaluation of the arrhythmic risk in patients with mitral valve prolapse
por: Guglielmo, Marco, et al.
Publicado: (2023)

Nutritional Challenges in Patients with Advanced Liver Cirrhosis
por: Stirnimann, Jessica, et al.
Publicado: (2019)

Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
por: Friedli, Christoph, et al.
Publicado: (2021)

Modeling MOG Antibody–Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations
por: Remlinger, Jana, et al.
Publicado: (2023)

Neural correlates of working memory and its association with metabolic parameters in early-treated adults with phenylketonuria
por: Abgottspon, Stephanie, et al.
Publicado: (2022)

A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease
por: Ryerson, Christopher J., et al.
Publicado: (2021)

OPERA: Long baseline neutrino oscillation experiment
por: Guler, M
Publicado: (2009)

Metabolite-Sensing G Protein-Coupled Receptors Connect the Diet-Microbiota-Metabolites Axis to Inflammatory Bowel Disease
por: Melhem, Hassan, et al.
Publicado: (2019)

Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder—MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders
por: Wagner, Franca, et al.
Publicado: (2018)

Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study
por: Diem, Lara, et al.
Publicado: (2020)

Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients
por: Hammer, Helly, et al.
Publicado: (2022)

Epigenetic Therapy in Lung Cancer – Role of microRNAs
por: Rothschild, Sacha I.
Publicado: (2013)

microRNA therapies in cancer
por: Rothschild, Sacha I
Publicado: (2014)

Targeted Therapies in Non-Small Cell Lung Cancer—Beyond EGFR and ALK
por: Rothschild, Sacha I.
Publicado: (2015)

New treatment options for ALK+ advanced non-small-cell lung cancer: critical appraisal of ceritinib
por: Rothschild, Sacha I
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_cl0t36m3pi4h6h5gigpoo3libd